Table: Chugai Pharm -6-MTH group results (IFRS)

Chugai Pharmaceutical

27/07/2020 08:00

Jul 27 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2020        Jun 30, 2019     Dec 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              368.12              320.29                     
                   (+14.9 pct)         (+12.3 pct)                  
  Operating          140.63               95.05                     
                   (+47.9 pct)         (+42.8 pct)                  
  Pretax
  Net                102.29               69.25                     
                   (+47.7 pct)         (+42.3 pct)                  
  EPS Basic         62.26 yen           42.18 yen                   
  EPS Diluted       62.18 yen           42.12 yen                   
  Ann Div                              140.00 yen                   
  -Q2 Div           75.00 yen           48.00 yen                   
  -Q4 Div                               92.00 yen        25.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T